Mucoepidermoid carcinoma natural history: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}{{AE}}{{MV}}
{{CMG}}{{AE}}{{MV}}
==Overview==
==Overview==
<ref name="pmid8842902">{{cite journal |vauthors=Plambeck K, Friedrich RE, Schmelzle R |title=Mucoepidermoid carcinoma of salivary gland origin: classification, clinical-pathological correlation, treatment results and long-term follow-up in 55 patients |journal=J Craniomaxillofac Surg |volume=24 |issue=3 |pages=133–9 |year=1996 |pmid=8842902 |doi= |url=}}</ref>


==Natural History==
==Natural History==
Line 15: Line 18:
* Prognosis is generally regarded good after surgical excision.
* Prognosis is generally regarded good after surgical excision.
* The overall recurrence rate after resection is 2%.
* The overall recurrence rate after resection is 2%.
==References==
{{Reflist|2}}
{{WS}}
{{WH}}
[[Category:Disease]]
[[Category:Oncology]]





Revision as of 19:33, 18 February 2016

Mucoepidermoid carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mucoepidermoid Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mucoepidermoid carcinoma natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mucoepidermoid carcinoma natural history

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mucoepidermoid carcinoma natural history

CDC on Mucoepidermoid carcinoma natural history

Mucoepidermoid carcinoma natural history in the news

Blogs on Mucoepidermoid carcinoma natural history

Directions to Hospitals Treating Mucoepidermoid carcinoma

Risk calculators and risk factors for Mucoepidermoid carcinoma natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

[1]


Natural History

  • Most patients with mucoepidermoid carcinoma are initially asymptomatic.
  • The symptoms of usually develop in the first and second decade of life, and initially patients complain of bone pain that is increased upon activity.
  • If left untreated, patients with mucoepidermoid carcinoma may develop a

Complications

  • Common complications of mucoepidermoid carcinoma, include:[2]

Prognosis

  • Prognosis is generally regarded good after surgical excision.
  • The overall recurrence rate after resection is 2%.



References

  1. Plambeck K, Friedrich RE, Schmelzle R (1996). "Mucoepidermoid carcinoma of salivary gland origin: classification, clinical-pathological correlation, treatment results and long-term follow-up in 55 patients". J Craniomaxillofac Surg. 24 (3): 133–9. PMID 8842902.
  2. Saglik Y, Altay M, Unal VS, Basarir K, Yildiz Y (2006). "Manifestations and management of osteochondromas: a retrospective analysis of 382 patients". Acta Orthopaedica Belgica. 72 (6): 748–55. PMID 17260614.

Template:WH Template:WS